14
12

SUPPORT for Patients and Communities Reauthorization Act of 2025

7/17/2025, 11:03 AM

Summary of Bill S 2121

This bill, designated as S. 2121 in the 119th Congress, aims to reauthorize specific programs addressing opioid use disorder prevention, treatment, and recovery. Introduced on June 18, 2025, the bill focuses on providing support and resources for combating the opioid crisis, likely including funding for interventions, treatment options, and recovery support services.

Congressional Summary of S 2121

SUPPORT for Patients and Communities Reauthorization Act of 2025

This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.

For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to

•    addressing substance use disorders with respect to pregnant and postpartum women,
•    prevention and recovery from substance use disorders for youth, 
•    housing for individuals in recovery from substance use disorders,
•    community organizations facilitating recovery from substance use disorders,
•    loan repayment for certain health care providers treating substance use disorders, 
•    prevention of overdoses of controlled substances,
•    treatment of children experiencing psychological trauma, and
•    mental and behavioral health education and training for medical and allied health students.

Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

Additionally, the bill establishes new requirements for HHS, including requirements relating to

•    protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
•    establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
•    reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Current Status of Bill S 2121

Bill S 2121 is currently in the status of Bill Introduced since June 18, 2025. Bill S 2121 was introduced during Congress 119 and was introduced to the Senate on June 18, 2025.  Bill S 2121's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of June 18, 2025

Bipartisan Support of Bill S 2121

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
7
Democrat Cosponsors
3
Republican Cosponsors
3
Unaffiliated Cosponsors
1

Policy Area and Potential Impact of Bill S 2121

Primary Policy Focus

Health

Alternate Title(s) of Bill S 2121

A bill to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
A bill to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.

Comments

Seven Cole profile image

Seven Cole

966

11 months ago

This bill helps many people.

Ryder Forbes profile image

Ryder Forbes

904

11 months ago

I can't believe this bill is passing. It's going to have a huge impact on healthcare in our country. I'm not happy about it at all.